EMA Post-Authorization Studies Often Miss Disclosure Rules

Challenges in Public Disclosure of Post-Authorization Studies A significant number of post-authorization studies registered with the European Medicines Agency (EMA) do not meet the legal requirements or recommended guidelines for publicly sharing their findings, according to research published in The BMJ. These post-authorization studies, often abbreviated as PAS, are specifically designed to gather additional real-world […]